25 million shares as part of buyout? This is a quote from the excellent Thomas Barnard article which Blafarm posted. I missed the jump in his reasoning, but others may be able to explain.
“If you were the CEO of an acquiring company, and you were thinking of buying CytoDyn, why would you wait? Well, maybe you would like a nice tight deal with management supporting the deal. Maybe you wait to September 30, so management has its 25 million share incentive plan voted on and all their shares in a row.“